Common Stock and Stockholders' Equity (Tables)
|
6 Months Ended |
Jul. 31, 2024 |
| Equity [Abstract] |
|
| Summary of Shares of Common Stock Reserved for Future Issuance |
Shares of common stock reserved for future issuance are as follows:
| | | | | | | July 31, 2024 | | Outstanding stock options and unvested RSUs and PSUs | 14,835,965 | | | Available for future stock option, RSU, and PSU grants | 19,919,771 | | | Available for Employee Stock Purchase Plan (“ESPP”) | 3,984,879 | | Total common stock reserved for future issuance as of July 31, 2024 | 38,740,615 | |
|
| Schedule of Restricted Stock Unit Activity |
A summary of the Company’s RSU activity and related information is as follows:
| | | | | | | | | | | | | Number of RSUs | | Weighted Average Grant Date Fair Value Per Share | | Outstanding at January 31, 2024 | 7,412,056 | | | $ | 31.08 | | | Granted | 3,546,546 | | | $ | 21.70 | | | Vested | (1,721,813) | | | $ | 29.89 | | | Forfeited or canceled | (687,893) | | | $ | 31.20 | | | Outstanding at July 31, 2024 | 8,548,896 | | | $ | 27.43 | |
|
| Schedule of Restricted Stock Unit Activity |
A summary of the Company’s PSU activity and related information is as follows:
| | | | | | | | | | | | | | | | | Number of PSUs | | Weighted Average Grant Date Fair Value Per Share | | Outstanding at January 31, 2024 | | 541,992 | | | $ | 35.08 | | Granted(1) | | 781,813 | | | $ | 21.62 | | | Vested | | (9,050) | | | $ | 41.17 | | | Forfeited or canceled | | (45,108) | | | $ | 39.02 | | | Performance adjustment for 2023 PSU Awards | | (487,834) | | | $ | 34.98 | | | Outstanding at July 31, 2024 | | 781,813 | | | $ | 27.73 | | (1) This amount represents awards granted at 100% attainment. |
|
| Schedule of Stock-based Compensation Expense |
Stock-based compensation expense included in the Company’s condensed consolidated statements of operations was as follows for the periods indicated (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended July 31, | | Six months ended July 31, | | 2024 | | 2023 | | 2024 | | 2023 | | Cost of revenue | $ | 1,508 | | | $ | 2,164 | | | $ | 3,264 | | | $ | 4,040 | | | Research and development | 11,842 | | | 12,773 | | | 23,064 | | | 22,874 | | | Sales and marketing | 8,116 | | | 8,317 | | | 16,063 | | | 14,268 | | | General and administrative | 10,900 | | | 12,283 | | | 22,915 | | | 21,900 | | Total stock-based compensation expense | $ | 32,366 | | | $ | 35,537 | | | $ | 65,306 | | | $ | 63,082 | |
|